Live Breaking News & Updates on Division Of Blood

Stay updated with breaking news from Division of blood. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

A 12-Year-Old Is First to Start New Sickle Cell Treatment

He s the first patient outside of a clinical trial to start a new genetic treatment that was shown in clinical trials to cure 88% of people of the hallmark symptoms of sickle cell disease. ....

United States , New Jersey , New York , David Jacobsohn , Kendric Cromer , Children National Hospital , Marrow Transplantation At Children National Hospital , New York Times , Division Of Blood , Twelve Year Old Kendric Cromer , National Hospital , Bluebird Bio , Marrow Transplantation ,

Orca-T Shows Feasibility as a Reduced-Intensity Transplant Strategy in Hematologic Malignancies

Robert S. Negrin, MD, discusses the use of Orca-T as a viable strategy for patients with hematologic malignancies undergoing allogeneic transplant. ....

United States , Stanford University , Samuel Strober , Roberts Negrin , Shimon Sakaguchi , Marrow Transplantation At Stanford University , Division Of Blood , International Blood Marrow Transplant Research , Marrow Transplantation , International Blood Marrow Transplant ,

Vice President of ASH Will Focus on Gene Therapies, ASH's Global Impact

The field of hematology is experiencing significant advancements as promising new therapies for malignancies and GVHD continue to emerge. ....

United States , Los Angeles , Stanford University , Robert Negrin , Roberts Negrin , European Hematology Association , Translational Research Training In Hematology , Bone Marrow Transplantation Stem Cell Processing Center , Marrow Transplantation At Stanford University , Division Of Blood , American Society Of Hematology , Health In Los Angeles , Annual Meeting , New Agent , Caspian Oliai , Global Mark , Marrow Transplantation , Blood Advances , Translational Research Training , Cellular Therapy Meetings , American Society , Accessed December , Gene Therapies ,

Dr Frank on the Background of Investigating CAR22 Therapy in Relapsed/Refractory LBCL

Matthew Frank, MD, PhD, discusses findings from prior research investigating a CD22-directed CAR T-cell therapy that informed the rationale for launching a phase 1 trial with this agent in patients with relapsed/refractory large B-cell lymphoma.
....

Matthew Frank , Stanford University , National Cancer Institute , Division Of Blood , Marrow Transplantation , Cellular Therapy , Non Hodgkin Lymphoma , Cart Cell Therapy , Onclive Tv , Relapsed Refractory Largeb Cell Lymphoma ,

Petition to End Maintenance of Certification Rallies More Than 10K Signers

Physicians push back on 'burdensome, costly' program ....

United States , Jennifer Henderson , Paul Teirstein , Aaron Goodman , Division Of Blood , University Of California San Diego , National Board Of Physicians , American Board , Internal Medicine , Marrow Transplantation , California San Diego , Medpage Today , National Board ,